Pagina inicial
Continue Watching
Últimos vídeos
Últimos vídeos
Brightcove Home Latest Listing
Oncology
Oncology
Brightcove Cards Listing
Hematology
Hematology
Brightcove Cards Listing
Popular em MedEnrich
Popular em MedEnrich
Popular in Sem nome
Oncospecials15m 30s
A Relevância dos Agentes TKI na era das imunoterapias para o tratamento do carcinoma de células Renais
ONCOPLUS apresenta: vídeo-aula com Dr. Denis Jardim na patologia de carcinoma de células renais.
oncologia
ccr
câncer renal
tki
sunitinibe
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/08-24/1724925503_67217438492b0b80.jpg.webp?itok=ETZ2iIu9)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/08-24/1724925503_67217438492b0b80.jpg.webp?itok=ETZ2iIu9)
A Relevância dos Agentes TKI na era das...
Mieloma múltiplo9m 20s
Integrating Pomalidomide Based Regimens in Multiple Myeloma
Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
pomalidomide-dexamethasone
rrmm management
progression-free survival
combination therapies
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/10-24/1728839650_fe69e73e9fdd5e87.jpg.webp?itok=1_IK_-SY)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/10-24/1728839650_fe69e73e9fdd5e87.jpg.webp?itok=1_IK_-SY)
Integrating Pomalidomide Based Regimens in Multiple...
Myelodysplastic Syndromes14m 13s
ASH 2022 Update on Myelodysplastic Syndromes
ASH 2022 - Update on Myelodysplastic Syndromes
low risk mds
venetoclax
viale -a
eln classification
low dose lenalidomide
tags: azacitidine
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721738326_d926e3cca68eb305.jpg.webp?itok=uW3J5bQf)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721738326_d926e3cca68eb305.jpg.webp?itok=uW3J5bQf)
ASH 2022 Update on Myelodysplastic Syndromes
Câncer de próstata11m 38s
Treatment Intensification in Metastatic Castration Sensitive Prostate Cancer
PEACE-1 clinical trial demonstrated that combining ADT and docetaxel with abiraterone acetate plus prednisone (AAP) improves both overall survival (OS) and radiographic progression-free-survival (rPFS) in men with de novo mCSPC.
treatment intensification
mhspc
triplet therapy
peace-1 clinical trial
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/12-24/1734450392_e5eee5b62ece3e48.jpg.webp?itok=dlbbtoph)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/12-24/1734450392_e5eee5b62ece3e48.jpg.webp?itok=dlbbtoph)
Treatment Intensification in Metastatic Castration...
14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
dose dense adjuvant chemotherapy
esmo
keynote -522
monarch -3 study
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721738320_c670b506e849dcb5.jpg.webp?itok=N67p0tHw)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721738320_c670b506e849dcb5.jpg.webp?itok=N67p0tHw)
ESMO 2022 Breast Cancer Comprehensive Coverage
Mieloma múltiplo17m 14s
Tratamento do mieloma múltiplo
Tratamento do mieloma multiplo_Dr Ederson Mattos
mm
mieloma múltiplo
tratamento
lenalidomida
nccn
ederson mattos
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/01-25/1736243192_28e9543663f52179.jpg.webp?itok=INRzMIq-)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/01-25/1736243192_28e9543663f52179.jpg.webp?itok=INRzMIq-)
Tratamento do mieloma múltiplo
14m 46s
ESMO 2022 Breast Cancer Comprehensive Coverage
View comprehensive coverage of Breast Cancer from ESMO 2022
dose dense adjuvant chemotherapy
esmo
keynote -522
monarch -3 study
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721738320_c670b506e849dcb5.jpg.webp?itok=N67p0tHw)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721738320_c670b506e849dcb5.jpg.webp?itok=N67p0tHw)
ESMO 2022 Breast Cancer Comprehensive Coverage
3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
her2 positive mbc
prolonged remission
trastuzumab duration
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721219909_74ab0806ddaf5fbb.jpg.webp?itok=c8Pky-YP)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721219909_74ab0806ddaf5fbb.jpg.webp?itok=c8Pky-YP)
Duration of trastuzumab in patients with Her2...
3m 56s
Duration of trastuzumab in patients with Her2 positive Metastatic Breast Cancer in prolonged remission
There are no randomized clinical trials addressing the continued use of Trastuzumab for Her2 positive MBC patients in prolonged remission and has become important and relevant clinical question.
her2 positive mbc
prolonged remission
trastuzumab duration
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721219909_74ab0806ddaf5fbb.jpg.webp?itok=c8Pky-YP)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/1721219909_74ab0806ddaf5fbb.jpg.webp?itok=c8Pky-YP)
Duration of trastuzumab in patients with Her2...
Câncer de próstata4m 19s
Integrating PARP inhibitors in the treatment of Prostate Cancer
Wherever possible all patients with prostate cancer should undergo both germinal and somatic BRCA mutation testing as they represent predictive biomarkers of greater sensitivity to treatment with PARP inhibitors.
profound clinical trial
parp inhibitors
brca mutation
1![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/12-24/1734450391_b75407f8cae26094.jpg.webp?itok=BipqjgZC)
![](/brazil/sites/g/files/nstucr146/files/styles/popular_video_thumbnail/public/brightcove/videos/images/posters/12-24/1734450391_b75407f8cae26094.jpg.webp?itok=BipqjgZC)